Solstice Advanced Materials/$SOLS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Solstice Advanced Materials
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
- Ticker
- $SOLS
- Sector
- Materials
- Primary listing
- NASDAQ
- Employees
- 4,100
- Headquarters
- Morris Plains, United States
- Website
- www.solstice.com
SOLS Metrics
BasicAdvanced
$9.6B
46.13
$1.31
-
$0.23
0.50%
Price and volume
Market cap
$9.6B
52-week high
$90.80
52-week low
$40.43
Average daily volume
2.1M
Dividend rate
$0.23
Financial strength
Current ratio
1.459
Quick ratio
0.807
Long term debt to equity
1.307
Total debt to equity
1.528
Dividend payout ratio (TTM)
725.71%
Interest coverage (TTM)
8.91%
Profitability
EBITDA (TTM)
892
Gross margin (TTM)
30.62%
Net profit margin (TTM)
5.13%
Operating margin (TTM)
16.97%
Effective tax rate (TTM)
50.17%
Revenue per employee (TTM)
$1,000,000
Management effectiveness
Return on assets (TTM)
7.64%
Return on equity (TTM)
11.26%
Valuation
Price to earnings (TTM)
46.13
Price to revenue (TTM)
2.347
Price to book
6.06
Price to tangible book (TTM)
13.32
Price to free cash flow (TTM)
53.7
Free cash flow yield (TTM)
1.86%
Free cash flow per share (TTM)
1.128
Dividend yield (TTM)
0.37%
Forward dividend yield
0.50%
Growth
Revenue change (TTM)
9.20%
Earnings per share change (TTM)
-59.55%
What the Analysts think about SOLS
Analyst ratings (Buy, Hold, Sell) for Solstice Advanced Materials stock.
Analyst projections of the future price of Solstice Advanced Materials stock.
Bulls say / Bears say
Second-quarter sales rose 11% year on year to $1.15 billion, and Solstice raised its 2026 sales and adjusted EPS guidance. Growth across several businesses gives the upgraded outlook a broader base than a single-product rebound. (Solstice Advanced Materials)
Nuclear sales grew 27% in the second quarter, and Solstice owns the only operating uranium-conversion facility in the United States. That scarce position gives it a distinct way to benefit from demand for nuclear fuel. (Solstice Advanced Materials, World Nuclear News)
Electronic-material sales rose 15% in the second quarter on semiconductor demand, while segment adjusted EBITDA increased 24%. A planned $49 million Buffalo R&D expansion could support further product development in advanced materials. (Solstice Advanced Materials, New York State)
Profit growth lagged sales growth: second-quarter adjusted EBITDA rose only 2% as sales climbed 11%, and the EBITDA margin fell 2.18 percentage points to 25.3%. The main segment’s margin also dropped sharply, leaving earnings sensitive to operating costs and product mix. (Solstice Advanced Materials)
The proposed settlement of litigation tied to the Metropolis plant is valued at $80 million and still requires court approval. The extent of any Department of Energy reimbursement is unclear, so the final cash cost remains uncertain. (WKMS, Solstice Advanced Materials)
Higher standalone-company costs and net interest expense partly offset Solstice’s higher sales in the second quarter. These ongoing costs can limit how much of its revenue growth reaches shareholders as net earnings. (Solstice Advanced Materials)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.
SOLS Financial Performance
Revenues and expenses
SOLS Earnings Performance
Company profitability
Upcoming events
No upcoming events
SOLS News
AllArticlesVideos
Funds containing SOLS
AllUSDEURGBP
Fund name | Fund size | $SOLS weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.29% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.29% |
Xtrackers MSCI World Small Cap$XSWC | $183M | 0.09% |
iShares MSCI World Small Cap£WLDS | $9B | 0.09% |
iShares MSCI World Small Cap€IUSN | $9B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.